ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Scaling up symptom screening for routine use in pediatric oncology: provincial implementation.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe importance of routine symptom screening in pediatric oncology is increasingly being recognized. The Pediatric Oncology Group of Ontario (POGO) is therefore committed to facilitating its implementation province-wide. The objective was to establish common symptom screening practices in Ontario, Canada, by determining baseline implementation characteristics including initial enrollment cohorts, symptom screening frequency and screening duration.
methodsPOGO's Guidelines and Implementation Program convened an in-person focus group of site representatives, methodologists and a patient advocate. The focus group aimed to establish initial minimum characteristics of the symptom screening and management program: which patient cohorts to include, symptom screening reminder frequency and symptom screening duration. The nominal group technique and simple voting procedures were used.
resultsUsing the nominal group technique with two rounds of voting, focus group members identified newly diagnosed or relapsed pediatric outpatients receiving ambulatory chemotherapy as the initial target cohort. Simple voting procedures determined that the initial minimum symptom screening frequency will be once weekly and that symptom screening will extend for 3 months. At 3 months, patients or families can opt to continue or stop.
conclusionWe convened a focus group to establish provincial minimum characteristics of a symptom screening and management program in pediatric oncology. The program will include outpatients who are newly diagnosed or relapsed receiving ambulatory chemotherapy. Symptom screening reminders will be sent weekly for 3 months. These efforts should improve quality of life of pediatric patients with cancer at the population level.
Indexed as
Identifiers
42667418What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.